Diagnostic Center | December 15, 2022
Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
More women centric initiatives being the need of the hour for holistic development
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Subscribe To Our Newsletter & Stay Updated
